Literature DB >> 10907571

Thrombolysis in the air. Air-ambulance paramedics flying to remote communities treat patients before hospitalization.

H Kapasi1, L Kelly, J Morgan.   

Abstract

PROBLEM ADDRESSED: First Nations* communities in the North have a high prevalence of coronary artery disease and type 2 diabetes and face an increasing incidence of myocardial infarction (MI). Many conditions delay timely administration of thrombolysis, including long times between when patients first experience symptoms and when they present to community nursing stations, delays in air transfers to treating hospitals, uncertainty about when planes are available, and poor flying conditions. OBJECTIVE OF PROGRAM: To develop a program for administration of thrombolysis on the way to hospital by air ambulance paramedics flying to remote communities to provide more rapid thrombolytic therapy to northern patients experiencing acute MIs. COMPONENTS OF PROGRAM: Critical care flight paramedics fly to northern communities from Sioux Lookout, Ont; assess patients; communicate with base hospital physicians; review an exclusion criteria checklist; and administer thrombolytics according to the Sioux Lookout District Health Centre/Base Hospital Policy and Procedure Manual. Patients are then flown to hospitals in Sioux Lookout; Winnipeg, Man; or Thunder Bay, Ont.
CONCLUSION: This thrombolysis program is being pilot tested, and further evaluation and development is anticipated.

Entities:  

Mesh:

Year:  2000        PMID: 10907571      PMCID: PMC2144947     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  19 in total

1.  Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of data from the EMIP study. European Myocardial Infarction Project.

Authors:  A Leizorovicz; M C Haugh; C Mercier; J P Boissel
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

2.  Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).

Authors:  J M Rawles
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

Review 3.  Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data.

Authors:  R G Wilcox
Journal:  Am J Cardiol       Date:  1996-12-19       Impact factor: 2.778

4.  The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.

Authors:  F H Sheehan; E Braunwald; P Canner; H T Dodge; J Gore; P Van Natta; E R Passamani; D O Williams; B Zaret
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

5.  Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators.

Authors:  M A Brouwer; J S Martin; C Maynard; M Wirkus; P E Litwin; F W Verheugt; W D Weaver
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

6.  Myocardial salvage with early anistreplase treatment.

Authors:  J M Rawles
Journal:  Clin Cardiol       Date:  1997-11       Impact factor: 2.882

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis.

Authors:  J P Boissel
Journal:  Int J Cardiol       Date:  1995-08       Impact factor: 4.164

9.  Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience.

Authors:  Y Rozenman; M S Gotsman; A T Weiss; C Lotan; M Mosseri; D Sapoznikov; S Welber; Y Hasin; D Gilon
Journal:  Int J Cardiol       Date:  1995-08       Impact factor: 4.164

10.  Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.

Authors:  E W Grijseels; M J Bouten; T Lenderink; J W Deckers; A W Hoes; J A Hartman; E van der Does; M L Simoons
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

View more
  1 in total

1.  Research electives in rural health care.

Authors:  L Kelly; J Rourke
Journal:  Can Fam Physician       Date:  2002-09       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.